Document:

EX-10.1

 Exhibit 10.1 

Execution Version 

SETTLEMENT AGREEMENT 

This SETTLEMENT AGREEMENT (the “Agreement”), dated as of April 13, 2021, is made and entered into by and among
KOHL’S CORPORATION, a Wisconsin corporation (the “Company”); MACELLUM BADGER FUND, LP (“Macellum”) and the other persons and entities listed on Schedule A hereto (collectively and together with Macellum, the
“Macellum Investors”); LEGION PARTNERS HOLDINGS, LLC (“Legion”) and the other persons and entities listed on Schedule B hereto (collectively and together with Legion, the “Legion Investors”); 4010
PARTNERS, LP (“4010”) and the other persons and entities listed on Schedule C hereto (collectively and together with 4010, the “4010 Investors”) and ANCORA ADVISORS, LLC (“Ancora”) and the other
persons and entities listed on Schedule D hereto (collectively and together with Ancora, the “Ancora Investors,” and collectively with the Macellum Investors, Legion Investors and 4010 Investors, the “Investor
Group” and each individually, an “Investor”). The Company and the Investor Group are each herein referred to as a “party” and collectively, the “parties”. 

WHEREAS, the Company and representatives of the Investor Group have engaged in discussions regarding various matters concerning the Company,
including matters concerning the Board of Directors of the Company (the “Board”); 
 WHEREAS, Macellum, on behalf of itself
and Investor Group, previously submitted a notice of intention to nominate nine candidates to serve as directors of the Company and stand for election at the 2021 annual meeting of shareholders of the Company (the “2021 Annual
Meeting”) and related materials, which notice was dated January 11, 2021 (the “Nomination Notice,” including any attachments and supplements made thereto); 

WHEREAS, on March 11, 2021, the Investor Group submitted a revised preliminary proxy statement intending to reduce its slate of director
candidates from nine candidates to five candidates (the “Remaining Investor Nominees”) to serve as directors of the Company and stand for election at the 2021 Annual Meeting and thereafter sought to revise the Nomination Notice
accordingly; 
 WHEREAS, as of the date of this Agreement, the Macellum Investors beneficially own common shares of the Company, par value
$0.01 per share (the “Common Shares”) and such other securities relating to the Company as set forth on Schedule A hereto; 

WHEREAS, as of the date of this Agreement, the Legion Investors beneficially own Common Shares and such other securities relating to the
Company as set forth on Schedule B hereto; 
 WHEREAS, as of the date of this Agreement, the 4010 Investors beneficially own Common Shares
and such other securities relating to the Company as set forth on Schedule C hereto; 
 WHEREAS, as of the date of this Agreement, the
Ancora Investors beneficially own Common Shares and such other securities relating to the Company as set forth on Schedule D hereto; and 
  

 WHEREAS, the Company and the Investor Group believe that the best interests of the Company
and its shareholders would be served at this time by, among other things, coming to an agreement with respect to the matters covered in this Agreement and by the Company and the Investor Group agreeing to the other covenants and obligations
contained herein. 
 NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and agreements contained in this
Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the parties to this Agreement, intending to be legally bound by this Agreement, agree as follows: 

1.    Board Matters; Board Nominations; and Related Agreements. 

(a)    Board Matters. 
  

	 	(i)	 In connection with the actions set forth below and otherwise contemplated by this Agreement, the Board has
relied on information and materials that the Investor Group and each New Director (as defined below) has provided to the Company, including interviews conducted of each New Director, information provided in the Nomination Notice, authorizations from
the Investor Group and/or the New Director with respect to background checks, information required to be or customarily disclosed by directors or director candidates in proxy statements or other filings under applicable law or stock exchange rules
or listing standards, information in connection with assessing eligibility, independence and other criteria applicable to directors, and the Board and the Nominating & ESG Committee of the Board (the “Nominating Committee”)
have assumed (and the Investor Group and New Directors have represented and warranted) that such information and materials, the director questionnaire and other customary director onboarding documentation provided by each New Director is or will be
fully completed, true and accurate. Based on such information, the Nominating Committee has reviewed and approved the qualifications of each New Director to serve as a member of the Board and meet the requirements to qualify as
“independent” as defined by the listing standards of the New York Stock Exchange (the “NYSE”) and by the Securities and Exchange Commission (the “SEC”). Concurrently with the effectiveness of this
Agreement, the Board will take all necessary action to, as promptly as practicable after the completion of the 2021 Annual Meeting, increase the size of the Board by three and appoint each of (A) Margaret Jenkins and Thomas Kingsbury (the
“New Directors”) as new directors of the Company and (B) Christine Day (the “Additional Independent Director”) as a new director of the Company, to fill the resulting vacancies from such newly created
directorships, each with a term expiring at the 2022 annual meeting of shareholders (the “2022 Annual Meeting”) or until such person’s earlier death, resignation, disqualification or removal. 

 

	 	(ii)	 Promptly following the execution of this Agreement, the Board shall take all necessary actions for the existing
ad hoc finance committee (the 

  
 2 

	 	
“Finance Committee”) to become a standing committee of the Board. The purpose of the Finance Committee, which will be further described in the charter of such committee, will
include assisting the Board on its oversight of existing debt and equity capital financing matters and capital allocation decisions made by the Company. Upon the appointment of the New Directors, the Board shall take all necessary actions to
immediately appoint Thomas Kingsbury to the Finance Committee. 

  

	 	(iii)	 The Company agrees that during the period commencing on the date hereof until the appointment of the New
Directors and the Additional Independent Director, the New Directors shall be observers to the Board (the “Observers”) and shall receive, on a confidential and restricted basis, copies of all documents distributed to the Board,
including, without limitation, notice of all meetings of the Board, all written consents executed by the Board, all materials prepared for consideration at any meeting of the Board, and all minutes related to each meeting of the Board occurring on
or after the date hereof contemporaneous with their distribution to the Board. The Observers shall have the right to attend and reasonably participate, but not vote, at all meetings of the Board during this period (whether such meetings are held in
person, telephonically or otherwise). The Observers will agree to comply with all policies applicable to the directors and officer of the Company that have been provided to the Observers. 

(b)    Service on Other Board Committees. Subject to Section 1(a)(ii) above, the Board
shall, in accordance with its customary governance processes, determine appropriate Board committee assignments for the New Directors and the Additional Independent Director taking into account the composition of the Board, committee assignments and
the needs and independence and eligibility requirements of the committees and, subject to the foregoing, appoint one or more of the New Directors and/or the Additional Independent Director who meet such requirements to one or more committees of the
Board (as long as each New Director and/or the Additional Independent Director meet the applicable independence standards and criteria for each such committee). 

(c)    Board Policies and Procedures. Each party acknowledges that each New Director (and any Replacement) and the
Additional Independent Director shall be governed by (i) all applicable laws and regulations, and (ii) all of the same policies, processes, procedures, codes, rules, standards and guidelines applicable to members of the Board and shall for
the avoidance of doubt be required to strictly adhere to the policies on confidentiality, insider trading and conflicts of interest imposed on all members of the Board. Each party acknowledges that each New Director (and any Replacement) and the
Additional Independent Director shall be required to provide the Company with such information and authorizations as reasonably requested from all members of the Board as is required to be disclosed under applicable law or stock exchange
regulations, in each case as promptly as necessary to enable the timely and accurate filing of the Company’s proxy statement and other periodic reports or legally required disclosures with the SEC and to applicable stock exchanges and
regulatory authorities, and the members of the Investor Group shall also provide such information as reasonably requested as may be required to be disclosed under 

  
 3 

 
applicable law or stock exchange regulations. The Company agrees that each New Director and the Additional Independent Director shall receive (i) the same compensation for service as a
director as the compensation received by other non-management directors on the Board, and (ii) such other benefits on the same basis as all other non-management
directors on the Board. 
 (d)    Replacement Process for New Directors. If, following the date of this Agreement
and prior to the earlier of the expiration of the Standstill Period, a New Director is unable to serve as an independent director of the Company for any reason or otherwise continue service on the Board (such director, the “Departing
Director”), the Investor Group shall have the right to propose privately to the Company a recommended replacement director nominee who meets the requirements to qualify as “independent” as defined by the listing standards of the
NYSE and by the SEC, who is unaffiliated with (and independent of) any member of the Investor Group, who is not a Remaining Investor Nominee and who possesses relevant financial and business qualifications for the Company, who will be appointed to
the Board expeditiously following such Departing Director’s departure from the Board and the approval of the Nominating Committee and Board after exercising their good-faith customary due diligence review and fiduciary duties and taking into
account relevant skillsets and the needs of the Board, including interviews with and background checks of any such suggested candidate and receipt and review of required information (and any director so appointed as a replacement, a
“Replacement”) and it being understood that the Investor Group may continue to propose privately an additional candidate in the event identified Replacement candidate is not approved by the Board. 

(e)    Additional Agreements for New Directors. As a condition for eligibility for appointment, any Replacement
will promptly (but in any event prior to being placed on the Board in accordance with this Agreement) submit to the Company (i) a fully completed copy of the Company’s director questionnaire and other customary director onboarding
documentation (including an authorization form to conduct a background check) required by the Company in connection with the appointment or election of new Board members, (ii) a written acknowledgement that such person, if elected as a director
of the Company, would be in compliance, and will comply with, all of the same policies, processes, procedures, codes, rules, standards and guidelines applicable to members of the Board and shall for the avoidance of doubt be required to strictly
adhere to the policies on confidentiality, insider trading and conflicts of interest imposed on all members of the Board and (iii) an executed customary confidentiality agreement in substantially the form entered into by the members of the
Board. 
 (f)    Additional Agreements. The Company agrees that the Board and all applicable committees of the
Board shall take all necessary actions to authorize and approve an amendment to the Company’s share repurchase program approved by the Board in March 2006 that would permit the continued repurchase of common stock in an amount up to an
aggregate purchase price of $2 billion. 
 2.    Voting. At each annual and special meeting of
shareholders held prior to the expiration of the Standstill Period (and at any action taken by consent of shareholders during such period), each of the Investors agrees to (i) appear at such shareholders’ meeting or otherwise cause all
Common Shares beneficially owned by each Investor and their respective Affiliates to be counted as present for purposes of establishing a quorum, (ii) vote, or cause to be voted, all Common Shares beneficially owned by each Investor and their
respective Affiliates on the 

  
 4 

 
Company’s proxy card or voting instruction form (a) in favor of each of the directors nominated by the Board and recommended by the Board in the election of directors and against any
proposals to remove any such members of the Board, (b) against any nominees to serve on the Board that have not been recommended by the Board and (c) with respect to all other matters other than a Voting Exempt Matter, in accordance with
the Board’s recommendations as identified in the Company’s proxy statement, and (iii) not execute any proxy card or voting instruction form in respect of such shareholders’ meeting other than the proxy card and related voting
instruction form being solicited by or on behalf of the Board (such proxy card and/or form, the “Company’s card”); provided, however, that notwithstanding the foregoing, in the event that both
Institutional Shareholders Services (“ISS”) and Glass Lewis & Co., LLC (“Glass Lewis”) recommend otherwise with respect to any proposal (other than the election or removal of directors), each of the Investors shall have
the right to vote on the Company’s card in accordance with the recommendation of ISS or Glass Lewis with respect to such proposal so long as no Investor publicly discloses such vote, except with respect to any proposals at the 2021 Annual
Meeting as presented in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 19, 2021; provided, further, that with respect to any Voting Exempt Matter, each of the Investors
shall have the ability to vote freely on the Company’s card so long as no Investor publicly discloses such vote. For purposes of this Section 2, a “Voting Exempt Matter” means, with respect to the Company:
(i) any merger, acquisition, recapitalization, restructuring, financing, share issuances, disposition, distribution, spin-off, sale or transfer of all or substantially all of the Company’s or any of
its Affiliates’ assets in one or a series of transactions, joint venture or other business combination of the Company or any of its Affiliates with a third party; or (ii) any implementation of takeover defenses not in existence as of the
date of this Agreement by the Company. During the Standstill Period, not later than five business days prior to each of the Company’s meetings of shareholders, each Investor shall vote in accordance with this Section 2
and shall not revoke or change any such vote. 
 3.    Standstill. 

(a)    From the date of this Agreement until the expiration of the Standstill Period (as defined below), each Investor
shall not, and shall cause its respective Affiliates, principals, directors, general partners, officers, employees and, to the extent acting on its behalf or at its direction, agents and other representatives (collectively, the “Related
Persons”) not to, directly or indirectly: 
  

	 	(i)	 make any announcement or proposal with respect to, or offer, seek, propose or indicate an interest in
(A) any form of business combination or acquisition or other transaction relating to assets or securities of the Company or any of its subsidiaries, (B) any form of restructuring, recapitalization or similar transaction with respect to the
Company or any of its subsidiaries or (C) any form of tender or exchange offer for the Common Shares, whether or not such transaction involves a Change of Control of the Company (it being understood that the foregoing shall not prohibit
Investors or their Affiliates from acquiring Common Shares by means other than a tender or exchange offer within the limitations set forth in Section 3(a)(iii)); 

  
 5 

	 	(ii)	 engage in any solicitation of proxies or written consents to vote (or withhold the vote of) any voting
securities of the Company, or conduct any binding or nonbinding referendum with respect to any voting securities of the Company, or assist or participate in any other way, directly or indirectly, in any solicitation of proxies (or written consents)
with respect to any voting securities of the Company, or otherwise become a “participant” in a “solicitation,” as such terms are defined in Instruction 3 of Item 4 of Schedule 14A and Rule
14a-1 of Regulation 14A, respectively, under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to vote (or withhold the vote of) any securities of the Company;

  

	 	(iii)	 purchase or otherwise acquire, or offer, seek, propose or agree to acquire (collectively, “Acquire”),
ownership (including beneficial ownership as defined in Rule 13d-3 under the Exchange Act) of any securities or indebtedness of the Company, any direct or indirect rights or options to acquire any such
securities, any derivative securities or contracts or instruments in any way related to the price of shares of Common Stock of the Company, or any assets or liabilities of the Company; provided that with respect to the Macellum Investors and the
Ancora Investors, to the extent such Investor sells Common Shares, such Investor may subsequently Acquire Common Shares up to an amount that is equal to such Investor’s beneficial ownership as set forth on Schedules A and D attached hereto,
respectively; provided further that with respect to the Legion Investors and the 4010 Investors, to the extent either Investor sells Common Shares, either Investor may subsequently Acquire Common Shares up to an amount that is equal to the Legion
Investors’ and the 4010 Investors’ combined beneficial ownership as set forth on Schedules B and C attached hereto; provided further that the exercise of any existing call options as of the date hereof shall not be deemed to violate this
provision so long as the aggregate beneficial ownership position of such Investor is not effected thereby; 

  

	 	(iv)	 seek to advise, encourage or influence any person with respect to the voting of (or execution of a written
consent in respect of) acquisition of or disposition of any securities of the Company; 

  

	 	(v)	 sell, offer or agree to sell, directly or indirectly, through swap or hedging transactions or otherwise, the
securities of the Company or any rights decoupled from the underlying securities held by the Investor Group to any person or entity not (A) a party to this Agreement, (B) a member of the Board, (C) an officer of the Company or
(D) an Affiliate of the Investor Group (any person or entity not set forth in clauses (A)—(D) shall be referred to as a “Third Party”) that would knowingly result in such Third Party, together with its Affiliates, owning,
controlling or otherwise having any beneficial or other ownership interest representing in the aggregate in excess of 4.9 % of the Common Shares outstanding at such time; 

  
 6 

	 	(vi)	 take any action in support of or make any proposal or request that constitutes (or would constitute if taken),
or make any public statement or, solely with respect to the following clauses (A), (C), (D) or (E), have a discussion with any known shareholder of the Company concerning or with the effect of: (A) advising, controlling, changing or influencing
the Board or management of the Company, including any plans or proposals to change the voting standard with respect to director elections, number or term of directors or to fill any vacancies on the Board, except as set forth in this Agreement,
(B) any change in the capitalization, stock repurchase programs and practices, or dividend policy of the Company, (C) any other change in the Company’s management, business, or corporate structure, (D) seeking to have the Company
waive or make amendments or modifications to the Company’s Certificate of Incorporation, as amended (the “Charter”) or Amended By-laws (the
“By-laws”), or other actions that may impede or facilitate the acquisition of control of the Company by any person, (E) causing a class of securities of the Company to be delisted from,
or to cease to be authorized to be quoted on, any securities exchange or (F) causing a class of securities of the Company to become eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act;

  

	 	(vii)	 pursuant to Rule 14a-1(l)(2)(iv) under the Exchange Act communicate
with shareholders of the Company or others; 

  

	 	(viii)	 engage in any course of conduct with the purpose of causing shareholders of the Company to vote contrary to the
recommendation of the Board on any matter presented to the Company’s shareholders for their vote at any meeting of the Company’s shareholders or by written consent; 

 

	 	(ix)	 call or seek to call, or request the call of, alone or in concert with others, any meeting of shareholders,
whether or not such a meeting is permitted by the Charter or By-laws, including any “town hall meeting”; 

  

	 	(x)	 deposit any Common Shares in any voting trust or subject any Common Shares to any arrangement or agreement with
respect to the voting of any Common Shares (other than any such voting trust, arrangement or agreement solely among the Investors or any Affiliates thereof that is otherwise in accordance with this Agreement); 

 

	 	(xi)	 act, seek, facilitate or encourage any person to submit nominations or proposals, whether in furtherance of a
“contested solicitation” or otherwise, for the appointment, election or removal of directors or otherwise with respect to the Company or seek, facilitate, encourage or take any other action with respect to the appointment, election or
removal of any directors; 

  

	 	(xii)	 form, join or in any other way participate in any “group” (within the meaning of
Section 13(d)(3) of the Exchange Act or otherwise) with respect to the Company or its securities; provided, however, that nothing in this 

  
 7 

	 	
Agreement shall limit the ability of an Affiliate of the Investor Group to join the “group” following the execution of this Agreement upon notice to the Company, so long as any such
Affiliate first agrees to be bound in writing by the terms and conditions of this Agreement (it being understood that any Schedule 13D amendment or other legally required update and the contents thereof may not violate any of the restrictions set
forth in this Agreement); 

  

	 	(xiii)	 demand a copy of the Company’s list of shareholders or its other books and records or make any request
under Section 180.1602 of the Wisconsin Business Corporation Law or Section 624 or Section 1315 of the New York Business Corporation Law or equivalent state or federal laws; 

 

	 	(xiv)	 commence, encourage, join as a party, or support any litigation, arbitration, derivative action in the name of
the Company or any class action or other proceeding against the Company or any of its current or former officers or directors, in each case with the intent of circumventing the provisions of this Section 3, or take any
action challenging the validity or enforceability of any of the provisions of this Section 3 or Section 24; provided, however, that the foregoing shall not prevent any Investor from
(A) bringing litigation against the Company to enforce the provisions of this Agreement, (B) making counterclaims with respect to any proceeding initiated by, or on behalf of, the Company against an Investor or (C) responding to or
complying with a validly issued legal process that neither the Investor Group nor any of their Affiliates initiated, encouraged or facilitated; provided that the Investor Group shall, to the extent permitted by law, provide the Company with notice
of such legal process and will cooperate with the Company, at the Company’s sole expense, in seeking a protective order or other remedy to the extent applicable; 

 

	 	(xv)	 engage in any short sale, forward contract or any purchase, sale or grant of any option, warrant, convertible
security, stock appreciation right or other similar right (including any put or call option or “swap” transaction) with respect to any security (other than a broad-based market basket or index) that includes, relates to or derives any
significant part of its value from a decline in the market price or value of the securities of the Company and which would, in the aggregate or individually, result in the Investor Group or any individual Investor or member thereof having a
“net long position” in the Company that is less than $0; 

  

	 	(xvi)	 make any request or submit any proposal to amend or waive the terms of this Section 3
other than through non-public communications with the Company that would not be reasonably expected to result in or involve public disclosure obligations for any party; or 

 

	 	(xvii)	 enter into any discussions, negotiations, agreements or understandings with any person or entity with respect
to any action the Investors are prohibited from taking pursuant to this Section 3, or advise, assist, knowingly 

  
 8 

	 	
encourage or seek to persuade any person or entity to take any action or make any statement with respect to any such action, or otherwise take or cause any action or make any statement
inconsistent with any of the foregoing. 

 Notwithstanding the foregoing, nothing in this Section 3
or elsewhere in this Agreement shall prohibit or restrict the Investor Group from: (A) communicating privately with the Board or any executive officer or director of the Company, regarding any matter, so long as such communications are not
intended to, and would not reasonably be expected to, require any public disclosure of such communications and subject to the confidentiality obligations to the Company of any such director or officer; (B) privately communicating to any of
their potential investors or their investors publicly available information that does not otherwise violate this Agreement regarding the Company consistent with prior practice in any of the Investors’ annual and quarterly investor letters,
provided such communications are not reasonably expected to be publicly disclosed and are understood by all parties to be private communications and not undertaken with the intent to circumvent Section 3 or
Section 24 of this Agreement; and (C) privately communicating to any shareholders of the Company about matters concerning the Company in a manner that otherwise does not violate this Agreement, provided such
communications are not reasonably expected to be publicly disclosed, are not undertaken with the intent to circumvent Section 3 or Section 24 of this Agreement and are understood by all parties to
be private communications. None of the Investors nor any of their Affiliates shall seek to do directly or indirectly through any director of the Company or other individual anything that would be prohibited under this Agreement if done by any of the
Investors or their Affiliates or their agents and representatives. 
 (b)    Notwithstanding anything set forth herein
to the contrary, upon the public announcement by the Company of entry into a definitive agreement for a transaction that would constitute a Change of Control and which Change of Control transaction was not encouraged, facilitated or solicited by any
of Investors or their Related Persons, this Agreement shall immediately and automatically terminate in its entirety and no party hereunder shall have any further rights or obligations under this Agreement; provided, however, no party shall be
released from any breach of this Agreement that occurred prior to the termination of this Agreement. 
 (c)    For
purposes of this Agreement: 
  

	 	(i)	 “Affiliate” shall mean any “Affiliate” as defined in Rule 12b-2 promulgated by the SEC under the Exchange Act; 

  

	 	(ii)	 “Associate” shall mean any “Associate” as defined in Rule 12b-2 promulgated by the SEC under the Exchange Act; 

  

	 	(iii)	 “beneficial owner” and “beneficial ownership” shall have the same meanings as
set forth in Rule 13d-3 promulgated by the SEC under the Exchange Act; 

  

	 	(iv)	 a “Change of Control” transaction shall be deemed to have taken place if (1) any person
is or becomes a beneficial owner, directly or indirectly, of 

  
 9 

	 	
securities of the Company representing more than 50% of the equity interests and voting power of the Company’s then outstanding equity securities, (2) the Company effects a merger or a stock-for-stock transaction with a third party whereby immediately after the consummation of the transaction the Company’s shareholders retain less than 50% of the equity
interests and voting power of the surviving entity’s then outstanding equity securities or (3) the Company sells all or substantially all of the Company’s assets to a third party; 

 

	 	(v)	 “person” or “persons” shall mean any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization or other entity of any kind or nature; and

  

	 	(vi)	 “Standstill Period” shall mean the period commencing on the date of this Agreement and ending
on the date that is 30 calendar days prior to the last day of the advance notice period for the submission by shareholders of non-proxy access director nominations for the 2022 Annual Meeting (as set forth in
the advance notice provisions of the By-laws; provided that if the By-laws are amended and restated such that the advance notice period is changed thereunder, the
Company shall disclose such deadline at least 30 days prior thereto) or such later date as may be agreed by the parties. 

(d)    At any time during the Standstill Period, upon reasonable written notice from the Company to a member of the
Investor Group, the Investor Group and each member thereof will promptly provide the Company with information regarding the amount of the securities of the Company beneficially owned by each such entity or individual or Affiliates thereof. 

4.    Representations and Warranties of the Company. The Company represents and warrants to the Investors
that (a) the Company has the corporate power and authority to execute the Agreement and to bind the Company to this Agreement; (b) this Agreement has been duly and validly authorized, executed and delivered by the Company, constitutes a
valid and binding obligation and agreement of the Company, and is enforceable against the Company in accordance with its terms, except as enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance or similar laws generally affecting the rights of creditors and subject to general equity principles; (c) it has received notice from (i) Steven Burd that he will be retiring from the Board no later than August 31, 2021 and
(ii) Frank Sica that he intends to retire and not stand for election at the 2022 Annual Meeting; and (d) the execution, delivery and performance of this Agreement by the Company does not violate or conflict with (i) any law, rule,
regulation, order, judgment or decree applicable to it, or (ii) result in any breach or violation of or constitute a default (or an event which with notice or lapse of time or both could become a default) under or pursuant to, or result in the
loss of a material benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational document, or any material agreement, contract, commitment, understanding or arrangement to which the Company is a
party or by which it is bound. 

  
 10 

 5.    Representations and Warranties of the Investors.
Each Investor, on behalf of itself, jointly and severally represents and warrants to the Company that (a)(i) as of the date of this Agreement, such Investor beneficially owns, directly or indirectly, only the number of Common Shares as described
opposite its name on Schedules A-D to this Agreement and each such schedule includes all Affiliates of any Investors that own any securities of the Company beneficially or of record and reflects all Common
Shares in which the Investors have any interest or right to acquire, whether through derivative securities, voting agreements or otherwise; (a)(ii) the other persons and entities listed on Schedule A hereto are all of the Affiliates of Macellum that
beneficially own, directly or indirectly, Common Shares; the other persons and entities listed on Schedule B hereto are all of the Affiliates of Legion that beneficially own, directly or indirectly, Common Shares; the other persons and entities
listed on Schedule C hereto are all of the Affiliates of 4010 that beneficially own, directly or indirectly, Common Shares; and the other persons and entities listed on Schedule D hereto are all of the Affiliates of Ancora that beneficially own,
directly or indirectly, Common Shares; (a)(iii) as of the date hereof, other than as disclosed herein, the Investor Group does not currently have, and does not currently have any right to acquire, any interest in any other securities of the Company
(or any rights, options or other securities convertible into or exercisable or exchangeable (whether or not convertible, exercisable or exchangeable immediately or only after the passage of time or the occurrence of a specified event) for such
securities or any obligations measured by the price or value of any securities of the Company or any of its controlled Affiliates, including any swaps or other derivative arrangements designed to produce economic benefits and risks that correspond
to the ownership of Common Shares, whether or not any of the foregoing would give rise to beneficial ownership (as determined under Rule 13d-3 promulgated under the Exchange Act), and whether or not to be
settled by delivery of Common Shares, payment of cash or by other consideration, and without regard to any short position under any such contract or arrangement; (b) this Agreement has been duly and validly authorized, executed and delivered by
such Investor, and constitutes a valid and binding obligation and agreement of such Investor, enforceable against such Investor in accordance with its terms, except as enforcement thereof may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance or similar laws generally affecting the rights of creditors and subject to general equity principles; (c) such Investor has the authority to execute the Agreement on behalf of itself and the
applicable Investor associated with that signatory’s name, and to bind such Investor to the terms of this Agreement, including by virtue of having sole voting and dispositive power over such Investor’s Common Shares; (d) each of the
Investors shall cause each of its respective Related Persons to comply with the terms of this Agreement, and (e) the execution, delivery and performance of this Agreement by such Investor does not violate or conflict with (i) any law,
rule, regulation, order, judgment or decree applicable to it or the New Directors, or (ii) result in any breach or violation of or constitute a default (or an event which with notice or lapse of time or both could become a default) under or
pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational document, agreement, contract, commitment, understanding or arrangement to which such
member is a party or by which it is bound. Each Investor represents and warrants that it has no voting commitments (written or oral) with any of the New Directors as of the date hereof and agrees that it shall not compensate or otherwise incentivize
any New Director for their service or action on the Board or enter into voting commitments, (written or oral) relating to the Company with any director or officer of the Company. Each Investor further represents and warrants that it does not have,
directly or indirectly, any agreements, arrangements or understandings with any 

  
 11 

 
person (other than their own representatives) with respect to its investment in the Company, any strategic, capital, management or other operational matter with respect to the Company, any
potential transaction involving the Company, or the acquisition, voting or disposition of any securities of the Company, except as otherwise disclosed publicly in the Investor Group’s Schedule 13D or definitive proxy statement filed with the
SEC prior to the date hereof. The Investors represent and warrant that no member of the Investor Group has any control or influence over any compensation or other monetary payments to be received by any of the New Directors in connection with their
service as a director of the Company and that none of the Investors are aware of any facts or circumstances that will prevent any New Director from exercising independent judgment with respect to any matter involving the Company or items that may
come before the Board or any of its committees. The Investors represent and warrant that the information previously provided to the Company is true, accurate and complete in all material respects. 

6.    Conclusion of Investor Group Matters. Effective immediately upon the execution of this
Agreement: 
 (a)    Each member of the Investor Group agrees that it will not, and that it will not permit any of its
affiliates, constituents or representatives to, (i) nominate or recommend for nomination any person for election at the 2021 Annual Meeting, directly or indirectly, (ii) submit any proposal for consideration at, or bring any other business
before, the 2021 Annual Meeting, directly or indirectly, (iii) initiate, encourage or participate in any “vote no,” “withhold” or other campaign with respect to the 2021 Annual Meeting, in each case, directly or indirectly
or (iv) publicly or privately encourage or support any other shareholder to take any of the actions described in this Section 6(a). 

(b)    The Investor Group, on behalf of itself and its Affiliates, and each member thereof irrevocably withdraws and
terminates (and shall be deemed to have so withdrawn and terminated) in their entirety all demands to inspect stocklist materials, books, records and documents of the Company previously submitted by any members thereof pursuant to Section 1315
of the New York Business Corporation Law or otherwise. 
 (c)    The Investor Group, on behalf of itself and its
Affiliates, and each member thereof irrevocably withdraws (and shall be deemed to have so withdrawn) (i) all director nominations and candidates and any related materials or notices submitted to the Company in connection therewith or related
to, including the Nomination Notice and (ii) its solicitation of proxies which is the subject of its definitive proxy statement. 

(d)    The Investor Group, on behalf of itself and its Affiliates, and each member thereof agrees not to take any further
action with respect to any solicitation materials related to the foregoing nominations or otherwise concerning the 2021 Annual Meeting or the Company filed by it or on its behalf with the SEC or provided to investors; provided,
however, that the Investor Group shall, promptly following the execution and delivery of this Agreement (and in any event no later than the second business day following the execution of this Agreement) file with the SEC definitive additional
materials supplementing its proxy statement for the 2021 Annual Meeting to disclose the withdrawal of all nominations of the Remaining Investor Nominees, and the fact that all votes (whether for withdrawn director nominees or any other agenda items)
on such previously submitted proxy cards will be disregarded. The Investor Group, on behalf of itself and its Affiliates, 

  
 12 

 
and each member thereof hereby further agrees that it will, and that it will cause its Affiliates and Associates and its or their respective representatives to immediately cease (and not resume)
any and all efforts, direct or indirect, in furtherance of any solicitation (including any negative solicitation efforts) in connection with the 2021 Annual Meeting, the Company or the Company’s business. 

(e)    The Investor Group, on behalf of itself and its Affiliates, and each member thereof, hereby terminates each of the
agreements attached to the Nomination Notice and releases any and all such counterparties, including the New Directors, from their obligations therein (and shall be deemed upon execution of this Agreement to have so terminated and released). The
Investor Group confirms that there does not exist any other agreement with any of the New Directors or other candidates for election which relate to the nomination or solicitation of proxies of director candidates for election or other matters to be
considered at the 2021 Annual Meeting. 
 7.    Public Announcements. No later than the first business day
following the execution of this Agreement, the Company and the Investor Group shall issue a mutually agreeable press release (the “Press Release”) announcing this Agreement, substantially in the form attached to this Agreement as
Exhibit A. Prior to the issuance of the Press Release, neither the Company nor any of the Investors shall issue any press release or make any public announcement regarding this Agreement or take any action that would require public disclosure
relating to such action without the prior written consent of the other party. Subject to applicable law, no party or any of its Affiliates shall make any public statement (including, without limitation, in any filing required under the Exchange Act)
concerning the subject matter of this Agreement inconsistent with the Press Release or the terms of this Agreement. 

8.    SEC Filings. 

(a)    No later than two business days following the execution of this Agreement, the Company shall file a Current Report
on Form 8-K with the SEC reporting the appointment of the New Directors and appending or incorporating by reference this Agreement as an exhibit, provided that the Company shall first preview such Current
Report with the Investors in advance of making such filing and consider comments by the Investors. No later than two business days following the execution of this Agreement, the Investor Group shall file an amendment to its Schedule 13D with the SEC
reporting its entry into this Agreement, disclosing applicable items to conform to its obligations hereunder and including the terms of this Agreement, conforming Item 4 thereof to the agreements and restrictions of this Agreement and including this
Agreement as an exhibit thereto (the “Schedule 13D Amendment”), provided that the Investor Group shall first preview the Schedule 13D Amendment with the Company in advance of making such filing and consider comments by the Company.

 (b)    None of the Investors shall, during the Standstill Period, (i) issue a press release regarding the
Company or in connection with this Agreement or the actions contemplated by this Agreement or (ii) otherwise make any public disclosure or announcement with respect to the Company or this Agreement or the actions contemplated by this Agreement,
in each case without the prior written consent of the Company, unless required by applicable law, rules or regulations in which case the Investor shall first preview such disclosure or announcement with the Company in advance of making such
disclosure or announcement and consider comments by the Company. 

  
 13 

 9.    Specific Performance. Each of the Investors, on the
one hand, and the Company, on the other hand, acknowledges and agrees that irreparable injury to the other party to this Agreement would occur in the event any of the provisions of this Agreement are not performed in accordance with their specific
terms or are otherwise breached and that such injury would not be adequately compensable in monetary damages. It is accordingly agreed that the Investors or any Investor, on the one hand, and the Company, on the other hand (the “Moving
Party”), shall each be entitled to specific enforcement of, and injunctive or other equitable relief as a remedy for any such breach or to prevent any violation or threatened violation of, the terms of this Agreement, and the other party to
this Agreement will not take action, directly or indirectly, in opposition to the Moving Party seeking such relief on the grounds that any other remedy or relief is available at law or in equity. The parties further agree to waive any requirement
for the security or posting of any bond in connection with any such relief. Such remedies shall not be deemed to be the exclusive remedies for a breach of this Agreement but shall be in addition to all other remedies available at law or equity. 

10.    Notice. Any notices, consents, determinations, waivers or other communications required or permitted
to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by email (provided confirmation of transmission is
mechanically or electronically generated and kept on file by the sending party), provided that such email notice is accompanied by a notice delivered pursuant to either clause (i) or (iii) within twenty-four hours of email receipt; or
(iii) one business day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses and email addresses for such communications shall be: 

If to the Company: 

Kohl’s Corporation 
 N56
W17000 Ridgewood Drive, 
 Menomonee Falls, Wisconsin 

Attn: Jason Kelroy, Senior Executive Vice President, General Counsel and Corporate Secretary 

Email: jason.kelroy@kohls.com 

with copies (which shall not constitute notice) to: 

Latham & Watkins 
 330
North Wabash Avenue, Suite 2800 
 Chicago, IL 60611 

Attn: Mark D. Gerstein and Christopher R. Drewry 

Email: mark.gerstein@lw.com; christopher.drewry@lw.com 

  
 14 

 Godfrey & Kahn, S.C. 

833 East Michigan Street, Suite 1800 

Milwaukee, WI 53202-5615 
 Attn:
Dennis Connolly and C.J. Wauters 
 Email: dconnoll@gklaw.com; cwauters@gklaw.com 

If to any Investor: 
 Macellum
Advisors GP, LLC 
 99 Hudson Street, 5th Floor 

New York, NY 10013 
 Attn:
Jonathan Duskin 
 Email: jduskin@macellumcap.com 

Legion Partners Asset Management, LLC 

12121 Wilshire Blvd, Suite 1240 

Los Angeles, CA 90025 
 Attn:
Christopher S. Kiper 
 Email: ckiper@legionpartners.com 

Ancora Holdings, Inc. 
 6060
Parkland Boulevard, Suite 200 
 Cleveland, OH 44124 

Attn: Jim Chadwick 
 Email:
jchadwick@ancora.net 
 4010 Capital, LLC 

48 Brookridge Drive 
 Greenwich,
CT 06830 
 Attn: Steven Litt 

Email: slitt@4010capital.com 

with copies (which shall not constitute notice) to: 

Olshan Frome Wolosky LLP 
 1325
Avenue of the Americas 
 New York, NY 10019 

Attn: Steve Wolosky and Elizabeth Gonzalez-Sussman 

Email:     swolosky@olshanlaw.com 

                egonzalez@olshanlaw.com 

11.    Governing Law. This Agreement and any claim, controversy or dispute arising under or related to this
Agreement, the relationship of the parties, and/or the interpretation and enforcement of the rights and duties of the parties shall be governed by and construed and enforced in accordance with the laws of the State of Wisconsin, without regard to
any conflict of laws provisions thereof. 
 12.    Jurisdiction. Each party to this Agreement agrees, on
behalf of itself and its Affiliates and Associates, that any actions, suits or proceedings arising out of or relating to this 

  
 15 

 
Agreement or the transactions contemplated by this Agreement will be brought solely and exclusively in any state or federal court in the State of Wisconsin (and the parties agree not to commence
any action, suit or proceeding relating to this Agreement or the transactions contemplated by this Agreement except in such courts), and further agrees that service of any process, summons, notice or document by U.S. registered mail to the
respective addresses set forth in Section 10 will be effective service of process for any such action, suit or proceeding brought against any party in any such court. Each party, on behalf of itself and its Affiliates and
Associates, irrevocably and unconditionally waives any objection to the laying of venue of any action, suit or proceeding arising out of this Agreement or the transactions contemplated by this Agreement, in any state or federal court in the State of
Wisconsin, and further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an improper or inconvenient forum. 

13.    Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER
THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO
ENFORCE THE FOREGOING WAIVER IN THE EVENT OF A LEGAL ACTION, (B) SUCH PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 13. 

14.    Entire Agreement. This Agreement constitutes the full and entire understanding and agreement among
the parties with regard to the subject matter of this Agreement, and supersedes all prior and contemporaneous agreements, understandings and representations, whether oral or written, of the parties with respect to the subject matter of this
Agreement. There are no restrictions, agreements, promises, representations, warranties, covenants or undertakings, oral or written, between the parties other than those expressly set forth in this Agreement. 

15.    Headings. The section headings contained in this Agreement are for reference purposes only and shall
not affect in any way the meaning or interpretation of this Agreement. 
 16.    Waiver. No failure on the
part of any party to exercise, and no delay in exercising, any right, power or remedy under this Agreement shall operate as a waiver of such right, power or remedy, nor shall any single or partial exercise of such right, power or remedy by such
party preclude any other or further exercise of such right, power or remedy or the exercise of any other right, power or remedy. 

17.    Remedies. All remedies under this Agreement are cumulative and are not exclusive of any other
remedies provided by law or equity. 

  
 16 

 18.    Construction. When a reference is made in this
Agreement to a Section, such reference shall be to a Section of this Agreement, unless otherwise indicated. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of
this Agreement. Whenever the words “include,” “includes” and “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” The words “hereof,”
“herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The word “will” shall be construed to have
the same meaning as the word “shall.” The words “dates hereof” will refer to the date of this Agreement. The word “or” is not exclusive. The definitions contained in this Agreement are applicable to the singular as well
as the plural forms of such terms. Any agreement, instrument, law, rule or statute defined or referred to herein means, unless otherwise indicated, such agreement, instrument, law, rule or statute as from time to time amended, modified or
supplemented. 
 19.    Severability. If any provision of this Agreement is held invalid or unenforceable
by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree shall remain in full force and effect to the
extent not held invalid or unenforceable. The parties further agree to replace such invalid or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the purposes of such invalid
or unenforceable provision. 
 20.    Amendment. This Agreement may be modified, amended or otherwise
changed only in a writing signed by the Company, on the one hand, and the Investors, on the other hand. 

21.    Successors and Assigns. The terms and conditions of this Agreement shall be binding upon and be
enforceable solely by the parties hereto and successors thereto. No party may assign this Agreement or any rights or obligations hereunder without, with respect to any Investor, the express prior written consent of the Company, and with respect to
the Company, the prior written consent of each of the Investors, and any assignment in contravention of the foregoing shall be null and avoid. 

22.    No Third-Party Beneficiaries. The representations, warranties and agreements of the parties contained
herein are intended solely for the benefit of the party to whom such representations, warranties or agreements are made, and shall confer no rights, benefits, remedies, obligations, or liabilities hereunder, whether legal or equitable, in any other
person or entity, and no other person or entity shall be entitled to rely thereon. 
 23.    Counterparts;
Facsimile / PDF Signatures. This Agreement and any amendments hereto may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.
This Agreement shall become effective when each party hereto shall have received a counterpart hereof signed by the other parties hereto. In the event that any signature to this Agreement or any amendment hereto is delivered by facsimile
transmission or by email delivery of a portable document format (.pdf or similar format) data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force
and effect as if such facsimile or “.pdf” signature page were an original thereof. 

  
 17 

 24.    Expenses. Each of the Company and the Investors
shall be responsible for its own fees and expenses incurred in connection with the negotiation, execution, and effectuation of this Agreement and the matters contemplated hereby, including, but not limited to attorneys’ fees incurred in
connection with the negotiation and execution of this Agreement and all other activities related to the foregoing; provided, however, that the Company shall reimburse the Investor Group, within 10 business days of the date that the Company receives
reasonable supporting documentation, for its reasonable documented out-of-pocket third party expenses, including legal fees and expenses, as actually incurred in
connection with the 2021 Annual Meeting, the Investor Group’s involvement with the Company prior to the date hereof and the negotiation and execution of this Agreement, in an amount not to exceed $1,000,000. 

25.    Mutual Non-Disparagement. 

(a)    Each Investor agrees that, until the expiration of the Standstill Period, neither it nor any of its Affiliates will,
and it will cause each of its Affiliates and Related Persons not to, directly or indirectly, in any capacity or manner, make, express, transmit, speak, write, verbalize or otherwise communicate in any way (or cause, further, assist, solicit,
encourage, support or participate in any of the foregoing), any remark, comment, message, information, declaration, communication or other statement of any kind, whether verbal, in writing, electronically transferred or otherwise, that might
reasonably be construed to be derogatory towards, or critical of, the Company or any of its past or present directors, officers, Affiliates, subsidiaries, employees, agents or representatives (collectively, the “Company
Representatives”), or that reveals, discloses, incorporates, is based upon, discusses, includes or otherwise involves any confidential or proprietary information of the Company or its subsidiaries or Affiliates, or to malign, harm,
disparage, defame or damage the reputation or good name of the Company, any Company Representative or the Company’s business; provided, however, that the foregoing shall not prevent the Investor Group from privately communicating to the
Company, or any directors or executive officers of the Company factual information based on publicly available information. Nothing herein or elsewhere in this Agreement shall restrict the ability of any person to comply with any subpoena or other
legal process or respond to a request for information from any governmental authority with jurisdiction over the party from whom information is sought. Within twenty-four hours of the execution of this Agreement, the Investor Group shall terminate
all access to www.createvalueatkohls.com and any other website hosted, directly or indirectly, by the Investor Group with respect to the Company. 

(b)    The Company agrees that, until the expiration of the Standstill Period, neither it nor any of its executive
officers or directors will, directly or indirectly, in any capacity or manner, make, express, transmit, speak, write, verbalize or otherwise communicate in any way (or cause, further, assist, solicit, encourage, support or participate in any of the
foregoing), any remark, comment, message, information, declaration, communication or other statement of any kind, whether verbal, in writing, electronically transferred or otherwise, that might reasonably be construed to be derogatory towards, or
critical of, any Investor or any of its past or present directors, officers, Affiliates, subsidiaries, employees, agents or representatives (collectively, the “Investor Representatives”), or that reveals, discloses, incorporates, is
based upon, discusses, includes or otherwise involves any confidential or proprietary information of any Investor or its Affiliates, or to malign, harm, disparage, defame or damage the reputation or good name of any Investor, any Investor
Representative or any Investor’s business; provided, however, that the 

  
 18 

 
foregoing shall not prevent private communications to the Investor Group or Investor Representatives of factual information based on publicly available information. Nothing herein or elsewhere in
this Agreement shall restrict the ability of any person to comply with any subpoena or other legal process or respond to a request for information from any governmental authority with jurisdiction over the party from whom information is sought.
Within twenty-four hours of the execution of this Agreement, the Company shall terminate all access to www.kohlsmomentum.com and any other website hosted, directly or indirectly, by the Company with respect to the Investor Group’s
nomination of directors for election at the 2021 Annual Meeting. 
 (c)    Notwithstanding the foregoing, nothing in
this Section 25 or elsewhere in this Agreement shall prohibit any party to this Agreement from making any statement or disclosure required under the federal securities laws or other applicable laws, rules or regulations so long as such
requirement is not due to a breach by any party of this Agreement; provided, that such party must, to the extent legally permissible and practicable, provide written notice to the other party at least five business days prior to making any such
statement or disclosure required under the federal securities laws or other applicable laws, and shall reasonably consider any comments of the other party. The limitations set forth in Sections 25(a) and 25(b) shall not prevent any party to
this Agreement from responding to any public statement made by the other party of the nature described in Sections 25(a) and 25(b) if such statement by the other party was made in breach of this Agreement. 

[Signature Page Follows] 

  
 19 

 IN WITNESS WHEREOF the parties have duly executed and delivered this Agreement as of the
date first above written. 
  

			
	KOHL’S CORPORATION
		
	By:	 	 /s/ Jason Kelroy

	Name:	 	Jason Kelroy
	Title:	 	Senior Executive Vice President,
	General Counsel & Corporate Secretary

  
 20 

					
	MACELLUM PARTIES:
		
		 	MACELLUM BADGER FUND, LP
	    	 	By: Macellum Advisors GP, LLC
		 	its general partner
			
		 	By:	 	 /s/ Jonathan S. Duskin

		 	Name:	 	Jonathan S. Duskin
		 	Title:	 	Sole Member
		
		 	MACELLUM BADGER FUND II, LP
		 	By: Macellum Advisors GP, LLC
		 	its general partner
			
		 	By:	 	 /s/ Jonathan S. Duskin

		 	Name:	 	Jonathan S. Duskin
		 	Title:	 	Sole Member
		
		 	MACELLUM ADVISORS, LP
		 	By: Macellum Advisors GP, LLC
		 	its general partner
			
		 	By:	 	 /s/ Jonathan S. Duskin

		 	Name:	 	Jonathan S. Duskin
		 	Title:	 	Sole Member
		
		 	MACELLUM ADVISORS GP, LLC
			
		 	By:	 	 /s/ Jonathan S. Duskin

		 	Name:	 	Jonathan S. Duskin
		 	Title:	 	Sole Member
		
		 	 /s/ Jonathan Duskin

		 	Jonathan Duskin

  
 21 

 
					
	LEGION PARTIES:
		
	    	 	LEGION PARTNERS, L.P. I
		 	By: Legion Partners Asset Management, LLC
		 	Investment Advisor
			
		 	By:	 	 /s/ Christopher S. Kiper

		 	Name:	 	Christopher S. Kiper
		 		 	Title: Managing Director
		
		 	LEGION PARTNERS, L.P. II
		 	By: Legion Partners Asset Management, LLC
		 	Investment Advisor
			
		 	By:	 	 /s/ Christopher S. Kiper

		 	Name:	 	Christopher S. Kiper
		 	Title:	 	Managing Director
		
		 	LEGION PARTNERS SPECIAL OPPORTUNITIES, L.P. XV
		 	By: Legion Partners Asset Management, LLC Investment Advisor
			
		 	By:	 	 /s/ Christopher S. Kiper

		 	Name:	 	Christopher S. Kiper
		 	Title:	 	Managing Director
		
		 	LEGION PARTNERS, LLC
		 	 By: Legion Partners Holdings, LLC

Managing Member

			
		 	By:	 	 /s/ Christopher S. Kiper

		 	Name:	 	Christopher S. Kiper
		 	Title:	 	Managing Member
		
		 	LEGION PARTNERS ASSET MANAGEMENT, LLC
			
		 	By:	 	 /s/ Christopher S. Kiper

		 	Name:	 	Christopher S. Kiper
		 	Title:	 	Managing Director

  
 22 

 
			
	LEGION PARTNERS HOLDINGS, LLC
		
	By:	 	 /s/ Christopher S. Kiper

	Name:	 	Christopher S. Kiper
	Title:	 	Managing Director
	
	 /s/ Christopher S. Kiper

	Christopher S. Kiper
	
	 /s/ Raymond White

	Raymond White

  
 23 

 
					
	4010 PARTIES:
		
		 	4010 PARTNERS, LP
	    	 	By: 4010 General Partner, LLC its General Partner
			
		 	By:	 	 /s/ Steven E. Litt

		 	Name:	 	Steven E. Litt
		 	Title:	 	Managing Member
		
		 	4010 GENERAL PARTNERS, LLC
			
		 	By:	 	 /s/ Steven E. Litt

		 	Name:	 	Steven E. Litt
		 	Title:	 	Managing Member
		
		 	4010 CAPITAL, LLC
			
		 	By:	 	 /s/ Steven E. Litt

		 	Name:	 	Steven E. Litt
		 	Title:	 	Managing Member
		
		 	 /s/ Steven E. Litt

		 	Steven E. Litt

  
 24 

 
					
	ANCORA PARTIES:
		
		 	ANCORA CATALYST INSTITUTIONAL, LP
	    	 	By: Ancora Alternatives LLC
		 	its General Partner
		
		 	By: Ancora Holdings, Inc.
		 	its Sole Member
			
		 	By:	 	 /s/ Frederick DiSanto

		 	Name:	 	Frederick DiSanto
		 	Title:	 	Chairman and Chief Executive Officer
		
		 	ANCORA CATALYST, LP
		 	By: Ancora Alternatives LLC
		 	its General Partner
		
		 	By: Ancora Holdings, Inc.
		 	its Sole Member
			
		 	By:	 	 /s/ Frederick DiSanto

		 	Name:	 	Frederick DiSanto
		 	Title:	 	Chairman and Chief Executive Officer
		
		 	ANCORA MERLIN, LP
		 	By: Ancora Alternatives LLC
		 	its General Partner
		
		 	By: Ancora Holdings, Inc.
		 	its Sole Member
			
		 	By:	 	 /s/ Frederick DiSanto

		 	Name:	 	Frederick DiSanto
		 	Title:	 	Chairman and Chief Executive Officer
		
		 	ANCORA MERLIN INSTITUTIONAL, LP
		 	By: Ancora Alternatives LLC
		 	its General Partner
		
		 	By: Ancora Holdings, Inc.
		 	its Sole Member
			
		 	By:	 	 /s/ Frederick DiSanto

		 	Name:	 	Frederick DiSanto
		 	Title:	 	Chairman and Chief Executive Officer

  
 25 

 
			
	ANCORA CATALYST SPV I LP SERIES M
	By: Ancora Alternatives LLC
	its General Partner
	
	By: Ancora Holdings, Inc.
	its Sole Member
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer
	
	ANCORA CATALYST SPV I LP SERIES N
	By: Ancora Alternatives LLC
	its General Partner
	
	By: Ancora Holdings, Inc.
	its Sole Member
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer
	
	ANCORA CATALYST SPV I LP SERIES O
	By: Ancora Alternatives LLC
	its General Partner
	
	By: Ancora Holdings, Inc.
	its Sole Member
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer
	
	ANCORA CATALYST SPV I LP SERIES P
	By: Ancora Alternatives LLC
	its General Partner
	
	By: Ancora Holdings, Inc.
	its Sole Member
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer

  
 26 

			
	ANCORA CATALYST SPV I SPC LTD
	SEGREGATED PORTFOLIO G
	By: Ancora Alternatives LLC
	its Investment Manager
	
	By: Ancora Holdings, Inc.
	its Sole Member
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer
	
	ANCORA ADVISORS, LLC
	By: Ancora Alternatives LLC
	its Sole Member
	
	By: Ancora Holdings, Inc.
	its Sole Shareholder
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer
	
	ANCORA ALTERNATIVES, LLC
	By: Ancora Holdings, Inc.
	its Sole Member
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer
	
	ANCORA FAMILY WEALTH ADVISORS, LLC
	By: Ancora Holdings, Inc.
	its Sole Member
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer
	
	THE ANCORA GROUP INC.
	By: Ancora Holdings, Inc.
	its Sole Shareholder
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer

  
 27 

			
	INVERNESS HOLDINGS, LLC
	By: Ancora Holdings, Inc.
	its Sole Member
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer
	
	ANCORA HOLDINGS, INC.
		
	By:	 	 /s/ Frederick DiSanto

	Name:	 	Frederick DiSanto
	Title:	 	Chairman and Chief Executive Officer
	
	 /s/ Frederick DiSanto

	Frederick DiSanto

  
 28 

 SCHEDULE A 

MACELLUM PARTIES 
  

			
	 Party
	  	 Beneficial Ownership

	Macellum Badger	  	272,218 Common Shares beneficially owned directly, including 34,900 shares underlying long call options currently exercisable and 1,000 shares held in record name.
		
	Macellum Badger II	  	8,397,514 Common Shares beneficially owned directly, including 1,205,100 shares underlying long call options currently exercisable.
		
	Macellum Advisors	  	As the investment manager of Macellum Badger and Macellum Badger II, Macellum Advisors may be deemed to beneficially own the 272,218 Common Shares beneficially owned directly by Macellum Badger, including 34,900 shares underlying
long call options currently exercisable and 8,397,514 Common Shares beneficially owned directly by Macellum Badger II, including 1,205,100 shares underlying long call options currently exercisable.
		
	Macellum GP	  	As the general partner of Macellum Badger, Macellum Badger II and Macellum Advisors, Macellum GP may be deemed to beneficially own the 272,218 Common Shares beneficially owned directly by Macellum Badger, including 34,900 shares
underlying long call options currently exercisable and 8,397,514 Common Shares beneficially owned directly by Macellum Badger II, including 1,205,100 shares underlying long call options currently exercisable.
		
	Jonathan Duskin	  	As the managing member of Macellum GP, Mr. Duskin may be deemed to beneficially own the 272,218 Common Shares beneficially owned directly by Macellum Badger, including 34,900 shares underlying long call options currently
exercisable and 8,397,514 Common Shares beneficially owned directly by Macellum Badger II, including 1,205,100 shares underlying long call options currently exercisable.

  
 29 

 SCHEDULE B 

LEGION PARTIES 
  

			
	 Party
	  	 Beneficial Ownership

	Legion Partners I	  	1,891,990 Common Shares beneficially owned directly, including 567,900 shares underlying long call options currently exercisable.
		
	Legion Partners II	  	111,360 Common Shares beneficially owned directly, including 43,000 shares underlying long call options currently exercisable.
		
	Legion Partners Special XV	  	108,400 Common Shares beneficially owned directly, including 25,900 shares underlying long call options currently exercisable.
		
	Legion LLC	  	As the general partner of each of Legion Partners I and Legion Partners II and co-general partner of Legion Partners Special XV, Legion LLC may be deemed to beneficially own the 1,891,990
Common Shares beneficially owned directly by Legion Partners I, including 567,900 shares underlying long call options currently exercisable, 111,360 Common Shares beneficially owned directly by Legion Partners II, including 43,000 shares underlying
long call options currently exercisable, and 108,400 Common Shares beneficially owned directly by Legion Partners Special XV, including 25,900 shares underlying long call options currently exercisable.
		
	 Legion Partners Asset
 Management
	  	As the investment advisor of each of Legion Partners I, Legion Partners II and Legion Partners Special XV, Legion Partners Asset Management may be deemed to beneficially own the 1,891,990 Common Shares beneficially owned directly by
Legion Partners I, including 567,900 shares underlying long call options currently exercisable, 111,360 Common Shares beneficially owned directly by Legion Partners II, including 43,000 shares underlying long call options currently exercisable, and
108,400 Common Shares beneficially owned directly by Legion Partners Special XV, including 25,900 shares underlying long call options currently exercisable.

  
 30 

			
	Legion Partners Holdings	  	100 Common Shares owned directly, all of which are held in record name. As the sole member of Legion Partners Asset Management and sole member of Legion LLC, Legion Partners Holdings may also be deemed to beneficially own the
1,891,990 Common Shares beneficially owned directly by Legion Partners I, including 567,900 shares underlying long call options currently exercisable, 111,360 Common Shares beneficially owned directly by Legion Partners II, including 43,000 shares
underlying long call options currently exercisable, and 108,400 Common Shares beneficially owned directly by Legion Partners Special XV, including 25,900 shares underlying long call options currently exercisable.
		
	Christopher S. Kiper	  	As a managing director of Legion Partners Asset Management and managing member of Legion Partners Holdings, Mr. Kiper may be deemed to beneficially own the 1,891,990 Common Shares beneficially owned directly by Legion Partners
I, including 567,900 shares underlying long call options currently exercisable, 111,360 Common Shares beneficially owned directly by Legion Partners II, including 43,000 shares underlying long call options currently exercisable, 108,400 Common
Shares beneficially owned directly by Legion Partners Special XV, including 25,900 shares underlying long call options currently exercisable, and the 100 Common Shares beneficially owned directly by Legion Partners Holdings.
		
	Raymond T. White	  	As a managing director of Legion Partners Asset Management and managing member of Legion Partners Holdings, Mr. White may be deemed to beneficially own the 1,891,990 Common Shares beneficially owned directly by Legion Partners
I, including 567,900 shares underlying long call options currently exercisable, 111,360 Common Shares beneficially owned directly by Legion Partners II, including 43,000 shares underlying long call options currently exercisable, 108,400 Common
Shares beneficially owned directly by Legion Partners Special XV, including 25,900 shares underlying long call options currently exercisable, and the 100 Common Shares beneficially owned directly by Legion Partners Holdings.

  
 31 

 SCHEDULE C 

4010 PARTIES 
  

			
	 Party
	  	 Beneficial Ownership

	4010 Capital	  	As the investment manager of 4010 Partners and co-general partner of Legion Partners Special XV, 4010 Capital may be deemed to beneficially own the 39,000 Common Shares beneficially owned
directly by 4010 Partners, including 11,000 shares underlying long call options currently exercisable and 108,400 Common Shares beneficially owned directly by Legion Partners Special XV, including 25,900 shares underlying long call options currently
exercisable.
		
	4010 Partners	  	39,000 Common Shares beneficially owned directly, including 11,000 shares underlying long call options currently exercisable.
		
	4010 General Partner	  	As the general partner of 4010 Partners, 4010 General Partner may be deemed to beneficially own the 39,000 Common Shares beneficially owned by 4010 Partners, including 11,000 shares underlying long call options currently
exercisable.
		
	Steven Litt	  	As a managing member of 4010 Capital, Mr. Litt may be deemed to beneficially own the 108,400 Common Shares beneficially owned directly by Legion Partners Special XV, including 25,900 shares underlying long call options
currently exercisable and 39,000 Common Shares beneficially owned directly by 4010 Partners, including 11,000 shares underlying long call options currently exercisable.

  
 32 

 SCHEDULE D 

ANCORA PARTIES 
  

			
	 Party
	  	 Beneficial Ownership

	Ancora Catalyst Institutional	  	532,220 Common Shares beneficially owned directly, including 84,900 shares underlying long call options currently exercisable.
		
	Ancora Catalyst	  	42,076 Common Shares beneficially owned directly, including 7,200 shares underlying long call options currently exercisable.
		
	Ancora Merlin	  	41,015 Common Shares beneficially owned directly.
		
	Ancora Merlin Institutional	  	463,398 Common Shares beneficially owned directly.
		
	Ancora SPV I Series M	  	579,504 Common Shares beneficially owned directly, including 87,600 shares underlying long call options currently exercisable.
		
	Ancora SPV I Series N	  	408,909 Common Shares beneficially owned directly, including 60,600 shares underlying long call options currently exercisable.
		
	Ancora SPV I Series O	  	402,753 Common Shares beneficially owned directly, including 59,700 shares underlying long call options currently exercisable.
		
	Ancora SPV I Series P	  	407,845 Common Shares beneficially owned directly, including 63,900 shares underlying long call options currently exercisable.

  
 33 

			
	Ancora Alternatives	  	As the investment advisor to each of Ancora Catalyst Institutional, Ancora Catalyst, Ancora Merlin, Ancora Merlin Institutional, Ancora SPV I Series M, Ancora SPV I Series N, Ancora SPV I Series O, Ancora SPV I Series P and
Ancora Segregated Portfolio G, Ancora Alternatives may be deemed to beneficially own the 532,220 Common Shares beneficially owned directly by Ancora Catalyst Institutional, including 84,900 shares underlying long call options currently exercisable,
42,076 Common Shares beneficially owned directly by Ancora Catalyst, including 7,200 shares underlying long call options currently exercisable, 41,015 Common Shares beneficially owned directly by Ancora Merlin, 463,398 Common Shares beneficially
owned directly by Ancora Merlin Institutional, 579,504 Common Shares beneficially owned directly by Ancora SPV I Series M, including 87,600 shares underlying long call options currently exercisable, 408,909 Common Shares beneficially owned
directly by Ancora SPV I Series N, including 60,600 shares underlying long call options currently exercisable, 402,753 Common Shares beneficially owned directly by Ancora SPV I Series O, including 59,700 shares underlying long call options currently
exercisable, 407,845 Common Shares beneficially owned directly by Ancora SPV I Series P, including 63,900 shares underlying long call options currently exercisable and 569,146 Common Shares beneficially owned directly by Ancora Segregated
Portfolio G, including 91,500 shares underlying long call options currently exercisable.
		
	Ancora Family Wealth	  	As the investment advisor of certain separately managed accounts (the “SMAs”), Ancora Family Wealth may be deemed to beneficially own 7,208 Common Shares held in the SMAs.
		
	Ancora Advisors	  	As the investment advisor of the Ancora Advisors SMA, Ancora Advisors may be deemed to beneficially own 422,259 Common Shares held in the Ancora Advisors SMA, including 103,800 shares underlying long call options currently
exercisable.

  
 34 

			
	 Ancora Catalyst SPV I SPC Ltd
 Segregated
Portfolio G,
 a Cayman Islands segregated portfolio
 company
(“Ancora Segregated Portfolio G”)
	  	569,146 Common Shares beneficially owned directly, including 91,500 shares underlying long call options currently exercisable.
		
	Ancora Holdings	  	As the sole member of each of Ancora Alternatives and Ancora Family Wealth, Ancora Holdings may be deemed to beneficially own the 532,220 Common Shares beneficially owned directly by Ancora Catalyst Institutional, including 84,900
shares underlying long call options currently exercisable, 42,076 Common Shares beneficially owned directly by Ancora Catalyst, including 7,200 shares underlying long call options currently exercisable, 41,015 Common Shares beneficially owned
directly by Ancora Merlin, 463,398 Common Shares beneficially owned directly by Ancora Merlin Institutional, 579,504 Common Shares beneficially owned directly by Ancora SPV I Series M, including 87,600 shares underlying long call options currently
exercisable, 408,909 Common Shares beneficially owned directly by Ancora SPV I Series N, including 60,600 shares underlying long call options currently exercisable, 402,753 Common Shares beneficially owned directly by Ancora SPV I Series O,
including 59,700 shares underlying long call options currently exercisable, 407,845 Common Shares beneficially owned directly by Ancora SPV I Series P, including 63,900 shares underlying long call options currently exercisable, 7,208 Common Shares
held in the SMAs, 569,146 Common Shares beneficially owned directly by Ancora Segregated Portfolio G, including 91,500 shares underlying long call options currently exercisable and 422,259 Common Shares held in the Ancora Advisors SMA, including
103,800 shares underlying long call options currently exercisable.

  
 35 

			
	Frederick DiSanto	  	As the Chairman and Chief Executive Officer of Ancora Holdings, Mr. DiSanto may be deemed to beneficially own the 532,220 Common Shares beneficially owned directly by Ancora Catalyst Institutional, including 84,900 shares
underlying long call options currently exercisable, 42,076 Common Shares beneficially owned directly by Ancora Catalyst, including 7,200 shares underlying long call options currently exercisable, 41,015 Common Shares beneficially owned directly by
Ancora Merlin, 463,398 Common Shares beneficially owned directly by Ancora Merlin Institutional, 579,504 Common Shares beneficially owned directly by Ancora SPV I Series M, including 87,600 shares underlying long call options currently exercisable,
408,909 Common Shares beneficially owned directly by Ancora SPV I Series N, including 60,600 shares underlying long call options currently exercisable, 402,753 Common Shares beneficially owned directly by Ancora SPV I Series O, including 59,700
shares underlying long call options currently exercisable, 407,845 Common Shares beneficially owned directly by Ancora SPV I Series P, including 63,900 shares underlying long call options currently exercisable, 7,208 Common Shares held in the SMAs,
569,146 Common Shares beneficially owned directly by Ancora Segregated Portfolio G, including 91,500 shares underlying long call options currently exercisable and 422,259 Common Shares held in the Ancora Advisors SMA, including 103,800 shares
underlying long call options currently exercisable.

  
 36 

 EXHIBIT A 

FORM OF PRESS RELEASE 

NOT FOR IMMEDIATE RELEASE 

(See attached) 

 Kohl’s and Investor Group Reach Agreement 

 

	 	•	 	 Margaret Jenkins, Thomas Kingsbury and Former lululemon athletica CEO Christine Day to join Kohl’s Board
as independent directors  

  

	 	•	 	 New directors bring strong retail, apparel and leadership expertise to support transformational strategy and
continued momentum 

  

	 	•	 	 Board expands existing share repurchase authorization to $2 billion 

 MENOMONEE FALLS, Wis. – April 14, 2021 – Kohl’s Corporation (NYSE: KSS) (“Kohl’s” or the
“Company”) today announced that it has entered into a settlement agreement with Macellum Advisors GP, LLC, Ancora Holdings, Inc., Legion Partners Asset Management, LLC, and 4010 Capital, LLC (collectively, the “Investor Group”),
which collectively own 9.3% of Kohl’s outstanding common stock, including options. 
 As part of the agreement, two new independent directors nominated
by the Investor Group, Margaret Jenkins and Thomas Kingsbury, will join the Kohl’s Board of Directors (the “Board”), as of the close of the 2021 Annual Meeting of Shareholders. An additional independent director identified by
Kohl’s and agreed to by the Investor Group, Christine Day, will join the Board at the same time. 
 “We are pleased to further strengthen our
Board with the addition of Christine, Margaret and Tom as part of our continued refreshment process” said Kohl’s Chairman Frank Sica. “Today’s agreement reflects our Board’s ongoing dialogue with our shareholders and our
commitment to maximizing long-term value for all stakeholders. We welcome the new directors and look forward to their perspectives as we continue to execute Kohl’s growth strategy.” 

Kohl’s CEO Michelle Gass said, “I look forward to working with our newly expanded Board to further advance our transformative strategy and deliver
results for shareholders. Amidst ongoing industry disruption and evolving consumer trends, we are uniquely positioned to build on our momentum and accelerate growth and profitability.” 

The Investor Group stated: “These new directors are all proven leaders in retail who will add valuable expertise to the Board. We are pleased to have
been able to reach this constructive resolution with the Company, and we are confident these changes will help further our shared goal of creating long-term value for shareholders. We are excited for the future at
Kohl’s.”     
 Additionally, the Company announced that it received notice from Steve Burd that he will retire from the Board
at the end of August 2021, and from Frank Sica that he will retire from the Board next year in connection with the Company’s 2022 Annual Meeting of Shareholders. 

Also, as part of the agreement: 
  

	 	•	 	 The Board’s existing ad hoc finance committee will become a standing Finance Committee of the Board, which
Thomas Kingsbury will join. The purpose of the Committee will include assisting the Board on its oversight of capital allocation decisions made by the Company. 

 

	 	•	 	 The Board expanded its existing share repurchase authorization to $2 billion. Similar to past practices, the
authorization may be utilized to repurchase shares at the Company’s discretion, subject to market conditions and other factors. 

The Investor Group will not be submitting WHITE Proxy Cards for tabulation for the 2021 Annual Meeting of Shareholders and encourages stockholders to submit a
BLUE proxy card in support of the Board’s recommendations on each proposal. All votes previously submitted on WHITE proxy cards (whether with respect to withdrawn directors or other agenda matters) will be disregarded in entirety. 

The Investor Group has also agreed to abide by certain customary standstill provisions until 30 days prior to the close of the nomination window for the
Company’s 2022 Annual Meeting of Shareholders. 

 The complete agreement will be filed by the Company with the U.S. Securities and Exchange Commission
(“SEC”) as an exhibit to the Current Report on Form 8-K. 
 About the New Directors 

Christine Day brings extensive expertise in retail, including experience in athleisure. Ms. Day is
co-founder and the Executive Chairman of The House of LR&C, a new concept in retail with a focus on fashion and sustainability and doing good, and currently serves on the board of directors of Performance
Kitchen. From 2008 to 2013, Ms. Day served as the CEO of lululemon athletica, where she was a key driver in the company’s significant growth in sales from less than $300 million to $1.5 billion and grew stores from less than 100
to 250. Prior to lululemon she spent more than 20 years at the Starbucks Corporation, in a variety of leadership positions including most recently as President of the Asia Pacific Group. 

Margaret Jenkins has extensive background in retail and consumer marketing management and advertising. Ms. Jenkins has served as a director
for clothing retailer Citi Trends Inc. as well as for PVH Corp., an international apparel manufacturer and retailer. She has also served as Chief Marketing Officer of restaurant corporations Denny’s Corporation and El Pollo Loco.
Ms. Jenkins also held several management positions with Taco Bell Corp. and PepsiCo International Foodservice. Ms. Jenkins is Chair of the Board of Directors of Prisma Health – Upstate, one of the largest healthcare providers in the
Southeast.  
 Thomas A. Kingsbury brings more than 40 years of experience in the retail industry. Mr. Kingsbury serves as an independent
director at Big Lots, Inc, BJ’S Wholesale Club Holdings, Inc., and at Tractor Supply Co. Most recently, he served as the President and CEO of Burlington Stores, Inc. from 2008 until his retirement in September 2019. Mr. Kingsbury also
served as a member of the board of directors of Burlington Stores from 2008 until February 2020, including as Chairman from May 2014 to September 2019 and as Executive Chairman from September 2019 to February 2020. Prior to Burlington Stores,
Kingsbury held various leadership positions at retail companies including Kohl’s and The May Department Stores Company. 
 Cautionary Statement
Regarding Forward-Looking Information 
 This press release contains “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. The Company intends forward-looking terminology such as “believes,” “expects,” “may,” “will,” “should,” “anticipates,” “strategy,”
“preliminary,” “plans,” or similar expressions to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause the Company’s actual results to differ materially from
those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to, our ability to execute on and realize the benefits of our strategic plan, market conditions beyond our control, including the ongoing
and evolving impact of the COVID-19 pandemic, that may negatively impact our stock price vis-à-vis industry analyst
expectations and the risks described more fully in Item 1A in the Company’s Annual Report on Form 10-K, which is expressly incorporated herein by reference, and other factors as may periodically be
described in the Company’s filings with the SEC. Forward-looking statements relate to the date initially made, and Kohl’s undertakes no obligation to update them. 

About Kohl’s 
 Kohl’s (NYSE: KSS) is a leading
omnichannel retailer. With more than 1,100 stores in 49 states and the online convenience of Kohls.com and the Kohl’s App, Kohl’s offers amazing national and exclusive brands at incredible savings for families nationwide. Kohl’s is
uniquely positioned to deliver against its strategy and its vision to be the most trusted retailer of choice for the active and casual lifestyle. Kohl’s is committed to progress in its diversity and inclusion pledges, and the company’s
environmental, social and corporate governance (ESG) stewardship. For a list of store locations or to shop online, visit Kohls.com. For more information about Kohl’s impact in the community or how to join our winning team, visit
Corporate.Kohls.com or follow @KohlsNews on Twitter. 

 Contacts 

Investor Relations: 
 Mark Rupe, (262) 703-1266, mark.rupe@kohls.com 
 Media: 

Jen Johnson, (262) 703-5241, jen.johnson@kohls.com 

Lex Suvanto, (646) 775-8337, lex.suvanto@edelman.comex_240871.htm

EXHIBIT 10.1

 

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT

 

THIS SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”) is made effective as of April 10, 2021 (the “Effective Date”) by and among by and among INTEST CORPORATION, a Delaware corporation, (“Borrower”), AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPORATION, a Delaware corporation, INTEST EMS, LLC, a Delaware limited liability company, and TEMPTRONIC CORPORATION, a Delaware corporation (each individually, a “Guarantor” and collectively, the “Guarantors”), and M&T BANK (“Lender”).

 

BACKGROUND

 

A.          Borrower, Guarantors and Lender have previously entered into a certain Loan and Security Agreement dated April 10, 2020, as amended by that certain First Amendment to Loan and Security Agreement dated December 16, 2020 (as amended and as the same may be amended, supplemented or restated from time to time, the “Loan Agreement”).

 

B.          Borrower, Guarantors and Lender are entering into this Amendment to amend certain terms and conditions in the Loan Agreement.

 

C.          Capitalized terms not otherwise defined in this Amendment shall have the meanings set forth therefor in the Loan Agreement.

 

NOW THEREFORE in consideration of the foregoing premises and intending to be legally bound, the parties hereto agree as follows:

 

1.           Amended Definitions. The following terms, as defined in Section 1.1 of the Loan Agreement, shall be and are hereby amended and restated to read, in their entirety, as follows:

 

“Contract Period means the period of time commencing on the date of this Agreement and expiring on April 9, 2024.”

 

“Maximum Revolving Credit Facility Amount means $10,000,000.”

 

2.           Amended and Restated Note. Coincident with the execution of this Amendment, Borrower shall execute and deliver to Lender a Amended and Restated Revolver Note in the principal amount of $10,000,000 (the “Amended and Restated Note”). The Amended and Restated Note shall be in form and content acceptable to Lender and re-evidence and increase the existing indebtedness of Borrower to Lender under the Revolver Note dated April 10, 2020, in the original principal amount of $7,500,000 (the “Existing Note”). All references to the “Revolver Note” in the Loan Agreement and other Loan Documents shall be deemed to be references to the Amended and Restated Note. The parties hereby expressly acknowledge and agree that the Amended and Restated Note merely re-evidences and increases the indebtedness evidenced by the Existing Note and is given in substitution for, and not as payment of, the Existing Note.

 

3.           Unused Facility Fee. Borrower agrees to pay Bank an unused facility fee in an amount equal to fifteen (15) basis points per annum times the Average Unused Portion of Maximum Revolving Credit Facility Amount. Such fee will be payable quarterly in arrears on the last day of each calendar quarter, pro-rated for the actual number of days in any partial quarter, commencing with the calendar quarter ending June 30, 2021.

 

 

 

 

4.           Amendment/References. The Loan Agreement and the Loan Documents are hereby amended to be consistent with the terms of this Amendment. All references in the Loan Agreement and the Loan Documents to (a) the “Loan Agreement” shall be deemed to be references to the Loan Agreement as amended by this Amendment and (b) the “Loan Documents” shall include this Amendment and all references to the “Loan Documents” shall be deemed to be references to the Loan Documents as amended by this Amendment.

 

5.           Conditions. The obligation of the Lender to enter into this Amendment shall be subject to the satisfaction of the following conditions:

 

5.1        Executed Amendment Documents. Borrower and Guarantors will have executed and delivered to Lender this Amendment, the Amended and Restated Note and any other documents required in connection with this Amendment.

 

5.2        Representations and Warranties.  All representations and warranties of Borrower and Guarantors set forth in the Loan Documents shall be true at and as of the date hereof.

 

5.3         No Default.   No condition or event shall exist or have occurred which would constitute a Default or an Event of Default.

 

5.4        Other.  All other documents and legal matters as required by Lender or its counsel in connection with the transactions contemplated by this Amendment shall have been delivered, executed or recorded.

 

6.           Covenants and Representations and Warranties.   Borrower and each Guarantor hereby:

 

6.1        ratifies, confirms and agrees that the Loan Agreement, as amended by this Amendment, and all other Loan Documents, are valid, binding and in full force and effect as of the date of this Amendment, and enforceable in accordance with their terms.

 

6.2        agrees that as of the date hereof it has no defense, set-off, counterclaim or challenge against the payment of any sums owed or owing under the Loan Agreement and the other Loan Documents or the enforcement of any of the terms of the Loan Agreement or the other Loan Documents.

 

6.3        ratifies, confirms and continues all liens, security interests, pledges, rights and remedies granted to Lender in the Loan Agreement and the other Loan Documents and agrees that such liens, security interests and pledges shall secure all of the Obligations under the Loan Agreement and the other Loan Documents as amended by this Amendment.

 

6.4        represents and warrants that all representations and warranties in the Loan Agreement and the other Loan Documents are true, correct and complete in all material respects as of the date of this Amendment unless such representation and warranty is made as of a specific date.

 

 

 

 

6.5        agrees that its failure to comply with or perform any of its covenants or agreements in this Amendment, after expiration of any applicable notice or cure periods, if any, as set forth in the Loan Agreement or other Loan Documents, will constitute an Event of Default under the Loan Agreement and the other Loan Documents.

 

6.6        represents and warrants that, to its knowledge, no condition or event exists after taking into account the terms of this Amendment which would constitute a Default or an Event of Default.

 

6.7        represents and warrants that the execution and delivery of this Amendment by Borrower and Guarantors and all documents and agreements to be executed and delivered pursuant to this Amendment:

 

(a)        has been duly authorized by all corporate and company action, as applicable, of Borrower and Guarantors;

 

(b)        will not conflict with or result in a breach of, or constitute a default under, any of the terms, conditions, or provisions of any applicable statute, law, rule, regulation or ordinance or Borrower’s or Guarantors Governing Documents or any indenture, mortgage, loan or credit agreement or instrument to which Borrower or any Guarantor is a party or by which it may be bound or affected, or any judgment or order of any court or governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign; and

 

(c)        will not result in the creation or imposition of any lien, charge or encumbrance of any nature whatsoever upon any of the property or assets of Borrower or Guarantors under the terms or provisions of any such agreement or instrument, except liens in favor of Lender.

 

7.            Additional Documents; Further Assurances.   Borrower and each Guarantor covenants and agrees to execute and deliver to Lender, or to cause to be executed and delivered to Lender contemporaneously herewith, at the sole cost and expense of Borrower and Guarantors, any and all other documents, agreements, statements, resolutions, certificates, consents and information as Lender may reasonably require in connection with the matters or actions described herein.   Borrower and each Guarantor further covenants and agrees to execute and deliver to Lender, or to cause to be executed and delivered, at the sole cost and expense of Borrower and Guarantors, from time to time, any and all other documents, agreements, statements, resolutions, certificates, consents and information as Lender shall reasonably request to evidence or effect the terms hereof or to enforce or protect Lender’s rights.  All of such documents, agreements, statements, resolutions, certificates, consents and information shall be in form and content reasonably acceptable to Lender.

 

8.           Certain Fees, Costs, Expenses and Expenditures. Borrower and each Guarantor agrees to pay all of Lender’s reasonable costs and expenses in connection with the review, preparation, negotiation, documentation and closing of this Amendment and the consummation of the transactions contemplated hereunder, including without limitation, costs, fees and expenses of counsel retained by Lender and all fees related to filings, recording of documents and searches, whether or not the transactions contemplated hereunder are consummated.  Nothing contained herein shall limit in any manner whatsoever Lender’s right to reimbursement under the Loan Agreement or any of the other Loan Documents.

 

 

 

 

9.           No Novation. Nothing contained herein and no actions taken pursuant to the terms hereof are intended to constitute a novation of the Loan Agreement or any of the other Loan Documents and shall not constitute a release, termination or waiver of any of the liens, security interests, rights or remedies granted to Lender in the Loan Agreement or the other Loan Documents.

 

10.         No Waiver.  Except as expressly provided herein, nothing herein contained and no actions taken by Lender in connection herewith shall constitute nor shall they be deemed to be a waiver, release or amendment of or to any rights, remedies, or privileges afforded to Lender under the Loan Agreement and the other Loan Documents.  Except as expressly provided herein, nothing herein shall constitute a waiver by Lender of Borrower’s or each Guarantor’s compliance with the terms of the Loan Agreement and the other Loan Documents, nor shall anything contained herein constitute an agreement by Lender to enter into any further amendments with Borrower or Guarantors.

 

11.         Inconsistencies.  To the extent of any inconsistency between the terms and conditions of this Amendment and the terms and conditions of the Loan Agreement or the other Loan Documents, the terms and conditions of this Amendment shall prevail.  All terms and conditions of the Loan Agreement and the other Loan Documents not inconsistent herewith shall remain in full force and effect and are hereby ratified and confirmed by Borrower and Guarantors.

 

12.         Binding Effect.  This Amendment and all rights and powers granted hereby will bind and inure to the benefit of the parties hereto and their respective permitted successors and assigns.

 

13.          No Third Party Beneficiaries.  The rights and benefits of this Amendment and the Loan Documents shall not inure to the benefit of any third party.

 

14.        Time of the Essence.  Time is of the essence in Borrower’s and Guarantors’ performance of its obligations under this Amendment and the Loan Documents.

 

15.         Headings.  The headings of the Articles, Sections, paragraphs and clauses of this Amendment are inserted for convenience only and shall not be deemed to constitute a part of this Amendment.

 

16.         Severability.  The provisions of this Amendment and all other Loan Documents are deemed to be severable, and the invalidity or unenforceability of any provision shall not affect or impair the remaining provisions which shall continue in full force and effect.

 

17.         Modifications.  No modifications of this Amendment, the Loan Agreement or any of the other Loan Documents shall be binding or enforceable unless in writing and signed by or on behalf of the party against whom enforcement is sought.

 

 

 

 

18.          Law Governing.  This Amendment has been made, executed and delivered in the Commonwealth of Pennsylvania and will be construed in accordance with and governed by the laws of such Commonwealth, without regard to any rules or principles regarding conflicts of law or any rule or canon of construction which interprets agreements against the draftsman.

 

19.         Counterparts; Electronic Signatures.  This Amendment and any notice or communication under this Amendment may be executed in one or more counterparts, each of which shall constitute an original, but all of which together shall constitute one and the same instrument. Delivery of a photocopy, telecopy, electronic mail (pdf) or other electronic transmission of an executed counterpart of a signature page to this Amendment shall be effective as delivery of a manually executed counterpart of this Amendment.

 

20.         Waiver of Right to Trial by Jury.  BORROWER, GUARANTORS AND LENDER WAIVE ANY RIGHT TO TRIAL BY JURY ON ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (a) ARISING UNDER THIS AMENDMENT OR ANY OF THE LOAN DOCUMENTS OR (b) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF BORROWER, GUARANTORS AND LENDER WITH RESPECT TO THIS AMENDMENT OR ANY OF THE LOAN DOCUMENTS OR THE TRANSACTIONS RELATED HERETO OR THERETO, IN EACH CASE WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE. BORROWER, GUARANTORS AND LENDER AGREE AND CONSENT THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AMENDMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF BORROWER, GUARANTORS AND LENDER TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. BORROWER AND GUARANTORS ACKNOWLEDGE THAT THEY HAVE HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL REGARDING THIS SECTION, THAT THEY FULLY UNDERSTANDS ITS TERMS, CONTENT AND EFFECT, AND THAT THEY VOLUNTARILY AND KNOWINGLY AGREE TO THE TERMS OF THIS SECTION.

 

 

 

 

21.         Restatement and Confirmation of Warrant of Attorney – Surety Agreement. The warrant of attorney to confess judgment contained in the Surety Agreement is hereby restated in its entirety and confirmed as follows:

 

	“24.         Confession of Judgment. GUARANTOR HEREBY IRREVOCABLY AUTHORIZES AND EMPOWERS ANY ATTORNEY OR THE PROTHONOTARY OR CLERK OF ANY COURT IN THE COMMONWEALTH OF PENNSYLVANIA, OR ELSEWHERE, TO APPEAR AT ANY TIME FOR GUARANTOR AFTER THE AMOUNTS HEREUNDER BECOME DUE FOLLOWING AN EVENT OF DEFAULT AND WITH OR WITHOUT COMPLAINT FILED, WITHOUT STAY OF EXECUTION, CONFESS OR ENTER JUDGMENT AGAINST GUARANTOR, AND EACH OF THEM JOINTLY AND SEVERALLY, FOR THE ENTIRE PRINCIPAL BALANCE OF THIS SURETY AGREEMENT AND ALL ACCRUED INTEREST, LATE CHARGES AND ANY AND ALL AMOUNTS EXPENDED OR ADVANCED BY BANK RELATING TO ANY COLLATERAL SECURING THE INDEBTEDNESS, TOGETHER WITH COSTS OF SUIT, AND AN ATTORNEY’S COMMISSION OF FIVE PERCENT (5%) OF THE UNPAID PRINCIPAL BALANCE AND ACCRUED INTEREST FOR COLLECTION, BUT IN ANY EVENT NOT LESS THAN THIRTY THOUSAND DOLLARS ($30,000.00) ON WHICH JUDGMENT OR JUDGMENTS ONE OR MORE EXECUTIONS MAY ISSUE IMMEDIATELY; AND FOR SO DOING, THIS GUARANTY OR A COPY OF THIS SURETY AGREEMENT VERIFIED BY AFFIDAVIT SHALL BE SUFFICIENT WARRANT. THE AUTHORITY GRANTED IN THIS SURETY AGREEMENT TO CONFESS JUDGMENT AGAINST GUARANTOR SHALL NOT BE EXHAUSTED BY ANY EXERCISE OF THAT AUTHORITY, BUT SHALL CONTINUE FROM TIME TO TIME AND AT ALL TIMES UNTIL PAYMENT IN FULL OF ALL AMOUNTS DUE UNDER THIS SURETY AGREEMENT. GUARANTOR HEREBY KNOWINGLY, VOLUNTARILY AND UNCONDITIONALLY WAIVES ANY RIGHT GUARANTOR MAY HAVE TO NOTICE OR TO A HEARING IN CONNECTION WITH ANY SUCH CONFESSION OF JUDGMENT AND STATES THAT EITHER A REPRESENTATIVE OF BANK SPECIFICALLY CALLED THIS CONFESSION OF JUDGMENT PROVISION TO GUARANTOR’S ATTENTION OR GUARANTOR HAS BEEN, OR HAS HAD THE OPPORTUNITY TO BE, REPRESENTED BY INDEPENDENT LEGAL COUNSEL. NOTWITHSTANDING THE PERCENTAGE ATTORNEYS COMMISSION STATED ABOVE, WHICH IS PROVIDED TO ESTABLISH A LIQUIDATED AMOUNT FOR THE PURPOSE OF PERMITTING BANK TO INCLUDE AN ATTORNEYS’ FEE IN A CONFESSED JUDGMENT, IF FOLLOWING ENTRY OF A JUDGMENT AGAINST BORROWER WHICH INCLUDES SUCH PERCENTAGE ATTORNEYS COMMISSION OF FEE, BORROWER OR GUARANTOR TENDERS TO BANK: (1) THE FULL AMOUNT OF THE PRINCIPAL, INTEREST, COSTS AND OTHER CHARGES OWED TO BANK INCLUDED IN SUCH JUDGMENT (EXCLUSIVE OF ATTORNEYS COMMISSIONS AND FEES CALCULATED ON A PERCENTAGE BASIS), PLUS (2) THE AMOUNT OF THE BANK’S NECESSARY, REASONABLE AND ACTUAL ATTORNEYS FEES ACTUALLY INCURRED BY BANK, BANK SHALL MARK SUCH JUDGMENT SATISFIED IN FULL.”

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the date first above written.

 

	
			 

				
			BORROWER:

				
			 

			
	 	 	 
	 	INTEST CORPORATION,	 
	 	a Delaware corporation	 
	
			 

				
			 

				
			 

				
			 

			
	
			 

				
			 

				
			 

				
			 

			
	
			 

				
			By: 

				
			/s/ Hugh T. Regan, Jr.

				
			 

			
	
			 

				
			Name/Title: Hugh T. Regan, Jr., CFO

				
			 

			
	
			 

				
			 

				
			 

				
			 

			
	 	GUARANTORS:	 
	 	 	 
	 	AMBRELL CORPORATION,	 
	 	a Delaware corporation	 
	 	 	 	 
	 	 	 	 
	 	By: 	/s/ Hugh T. Regan, Jr.	 
	 	Name/Title: Hugh T. Regan, Jr., CFO	 
	 	 	 	 
	 	INTEST SILICON VALLEY CORPORATION,	 
	 	a Delaware corporation	 
	 	 	 	 
	 	 	 	 
	 	By: 	/s/ Hugh T. Regan, Jr.	 
	 	Name/Title: Hugh T. Regan, Jr., CFO	 
	 	 	 	 
	 	INTEST EMS, LLC,	 
	 	a Delaware limited liability company	 
	 	 	 	 
	 	 	 	 
	 	By: 	/s/ Hugh T. Regan, Jr.	 
	 	Name/Title: Hugh T. Regan, Jr., CFO	 
	 	 	 	 
	 	 	 	 
	 	TEMPTRONIC CORPORATION,	 
	 	a Delaware corporation	 
	 	 	 	 
	 	 	 	 
	 	By: 	/s/ Hugh T. Regan, Jr.	 
	 	Name/Title: Hugh T. Regan, Jr., CFO	 

 

 

 

 

 

 

[Signature Page to Second Amendment to Loan and Security Agreement]

 

 

 

 

	 	BANK:	 
	 	 	 
	 	M&T BANK	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By: 	/s/ Steven A. Vilardi	 
	 	 	Steven A. Vilardi, Vice President	 

 

 

 

 

 

 

[Signature Page to Second Amendment to Loan and Security Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]